Efficient. Ethical. Experienced.
Superior central independent review board services that effectively balance the needs of human subjects, sponsors, and sites.
Exceptionally quick turnaround times to accelerate your clinical research.
Independently owned and operated means you work directly with us without bureaucratic hoops.
The United States Food and Drug Administration (FDA) released a new draft guidance as part of its stated commitment to assist sponsors and expedite drug development for rare pediatric diseases, Outsourcing-Pharma.com reports. FDA collaborated with the...
The Power of LinkedIn for Life Science Professionals – Diana Caldwell to deliver presentation at Purdue Foundry
Join Diana Caldwell, President and CEO of Pearl IRB, this Friday, December 1, 2017 at Purdue Foundry as she discusses "The Power of LinkedIn for Life Science Professionals." Foundry Grounds occurs each Friday and involves conversations, presentations &...
Gretchen Bowker, COO and Head of Quality at Pearl IRB, will discuss the regulatory approval process at the VisionTech Partners meeting on Thursday, November 30, 2017. The event, "Don't Wine about FDA - Regulatory 101 with Pearl Pathways," is open to...